Group 1 - The core viewpoint of the article highlights the current financial performance and market position of Weili Medical, indicating a low PE ratio compared to the industry average [1][3] - As of July 16, Weili Medical's closing price was 13.44 yuan, with a PE ratio of 17.26, marking a new low in 151 days, and a total market capitalization of 3.936 billion yuan [1] - The average PE ratio for the medical device industry is 51.87, with a median of 37.48, positioning Weili Medical at the 40th rank within the industry [1][3] Group 2 - Weili Medical specializes in the research, production, and sales of medical devices in various fields, including anesthesia, urology, and respiratory care, with products widely used in surgeries and emergency care [2] - The latest quarterly report for Q1 2025 shows Weili Medical achieved a revenue of 348 million yuan, representing a year-on-year increase of 12.60%, and a net profit of 58.92 million yuan, up 17.25%, with a gross profit margin of 44.78% [2]
维力医疗收盘上涨2.13%,滚动市盈率17.26倍,总市值39.36亿元